| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/09/2006 | US20060051425 Method of microencapsulation |
| 03/09/2006 | US20060051424 Compositions of oral gene therapy and methods of using same |
| 03/09/2006 | US20060051423 Chitosan-based transport system |
| 03/09/2006 | US20060051422 Stabilised solid drug dispersions in an organic carrier and a process for preparing the same |
| 03/09/2006 | US20060051421 Stable pharmaceutical formulations of benzimidazole compounds |
| 03/09/2006 | US20060051420 Pharmaceutical tablets containing tibolone and a coating |
| 03/09/2006 | US20060051419 Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
| 03/09/2006 | US20060051418 Pharmaceutical formulations of potassium ATP channel openers and uses thereof |
| 03/09/2006 | US20060051417 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
| 03/09/2006 | US20060051416 Modified release formulations of memantine oral dosage forms |
| 03/09/2006 | US20060051415 Method of enhancing absorptions of transmucosal administration formulations |
| 03/09/2006 | US20060051414 Fast water-dispersible domperidone tablets |
| 03/09/2006 | US20060051413 Administering drug (propranolol, scopolamine, estradiol) across mucosal membrane at a pH of pH=-log(Ka*SiSu): Ka = ionization constant (dissociation constant) of the compound in water, Si = solubility of the ionized form, and Su = solubility of the non-ionized form; sublingual; cardiovascular disorders |
| 03/09/2006 | US20060051412 Method for producing an immediately decomposing oral form of administration which releases active ingredients |
| 03/09/2006 | US20060051411 Antibacterial medicinal composition of enhanced oral absorptivity |
| 03/09/2006 | US20060051410 Pharmaceutical composition containing 2,2-dichloro-12-(4-chlorophenyl)-dodecanoic acid |
| 03/09/2006 | US20060051409 Bezonatate liquid hard capsule dosage form |
| 03/09/2006 | US20060051408 Microcapsules for stabilization of cosmetic, pharmaceutical or food products |
| 03/09/2006 | US20060051407 Method of treating ischemia-reperfusion injury |
| 03/09/2006 | US20060051406 Formulation of insoluble small molecule therapeutics in lipid-based carriers |
| 03/09/2006 | US20060051405 Compositions for the delivery of therapeutic agents and uses thereof |
| 03/09/2006 | US20060051404 Microstructure roller system |
| 03/09/2006 | US20060051401 Controlled nanofiber seeding |
| 03/09/2006 | US20060051391 Device for the controlled administration of substances to be inserted in a body cavity |
| 03/09/2006 | US20060051381 Cytokine antagonists for neurological and neuropsychiatric disorders |
| 03/09/2006 | US20060051372 Antigenic compounds |
| 03/09/2006 | US20060051300 Formulations and methods for treating rhinosinusitis |
| 03/09/2006 | US20060051299 Fluticasone powders has specific particle size distribution; increase bioavailability, prolonged therapeutic effect of the drug substance; aqueous suspension for inhalation; drug delivery method and device; rhinitis treatment |
| 03/09/2006 | US20060051298 Abuse resistent pharmaceutical dosage and method of making same |
| 03/09/2006 | US20060051297 Ultrasound contrast agents and process for the preparation thereof |
| 03/09/2006 | US20060051296 Thickened beverages for dysphagia |
| 03/09/2006 | US20060049269 Generation of therapeutic microfoam |
| 03/09/2006 | DE10253623B4 Bioabbaubare kolloidale Partikel, insbesondere für pulmonale Applikationen Biodegradable colloidal particles, in particular for pulmonary applications |
| 03/09/2006 | DE102004039875A1 Nanotransportsystem mit dendritischer Architektur Nanocarrier system with dendritic architecture |
| 03/09/2006 | CA2578921A1 Intracellular drug delivery improving liposome |
| 03/09/2006 | CA2578784A1 Compositions containing alpha-2-adrenergic agonist components |
| 03/09/2006 | CA2578552A1 Medicinal composition for percutaneous perospirone administration |
| 03/09/2006 | CA2578474A1 Controlled release dosage forms combining immediate release and sustained release of low-solubility drug |
| 03/09/2006 | CA2578442A1 Pharmaceutical compositions comprising 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-phenoxy}-pyridine-2-carboxylic acid methyl amide for the treatment of cancer |
| 03/09/2006 | CA2578438A1 Pharmaceutical compositions comprising 4-(4-(3-(4-chloro-3-trifluoro methyl-phenyl)-ureido)-3-fluoro-phenoxy)-pyridine-2-carboxylic acid |
| 03/09/2006 | CA2578224A1 Pharmaceutical formulations of potassium atp channel openers and uses thereof |
| 03/09/2006 | CA2577963A1 Compositions and methods for activating protein synthesis and deactivating catabolic processes in skeletal muscle |
| 03/09/2006 | CA2577852A1 Pharmaceutical dosage forms comprising a low-solubility drug and a polymer |
| 03/09/2006 | CA2577709A1 Multi-cap reservoir devices for controlled release or exposure of reservoir contents |
| 03/09/2006 | CA2577451A1 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b and other therapeutic proteins |
| 03/09/2006 | CA2577311A1 Pharmaceutical multiparticulate compositions comprising mycophenolic acid or mycophenolate sodium and combination compositions with rapamycin |
| 03/09/2006 | CA2577268A1 Neuroprotective effect of solubilized udca in focal ischemic model |
| 03/09/2006 | CA2576275A1 Multiparticulates with controlled release properties and free of lubricant |
| 03/08/2006 | EP1632561A1 Protein-containing granules and granule formulations |
| 03/08/2006 | EP1632281A1 Process for absorbing hydrophobic substances in polymers having an hollow structure |
| 03/08/2006 | EP1632259A2 Anti-angiogene compositions and methods of use |
| 03/08/2006 | EP1632246A2 Medicament for local use |
| 03/08/2006 | EP1632239A1 Pharmaceutical composition comprising a Pseudomonas lindbergii supernatant and a Bacillus coagulans supernatant and its use |
| 03/08/2006 | EP1632238A1 Encapsulated cells adapted for implantation into the aqueous and vitreous humor of the eye |
| 03/08/2006 | EP1632231A2 Skin penetration enhancing components |
| 03/08/2006 | EP1632226A1 Anti-inflammatory analgesic adhesive patch |
| 03/08/2006 | EP1632225A1 Drug nano-particle, method and apparatus for preparing pharmaceutical preparation using the particle |
| 03/08/2006 | EP1632224A1 Spill resistant pharmaceutical compositions |
| 03/08/2006 | EP1632208A1 Aerosol preparation comprising sealed container and enclosed therein aerosol composition containing macrolide compound |
| 03/08/2006 | EP1632137A1 Compositions and processes for water-dispersible phytosterols and phytostanols |
| 03/08/2006 | EP1631669A2 Cochleate compositions directed against expression of proteins |
| 03/08/2006 | EP1631375A2 Injectable hydrogel microspheres from aqueous two-phase system |
| 03/08/2006 | EP1631373A1 Micropellets, method for the production thereof, and use thereof |
| 03/08/2006 | EP1631331A1 A bioabsorbable delivery system |
| 03/08/2006 | EP1631318A2 Magnetic nanoparticles linked to a ligand |
| 03/08/2006 | EP1631309A2 Protein kinase c peptides for use in withdrawal |
| 03/08/2006 | EP1631308A2 Novel methods and compositions for enhanced transmucosal delivery of peptides and proteins |
| 03/08/2006 | EP1631301A1 Combination chemotherapy comprising 5-fluorouracil or a derivative thereof and a liposomal platinum complex |
| 03/08/2006 | EP1631300A2 High molecular weight polymers, devices and method for making and using same |
| 03/08/2006 | EP1631297A2 Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents |
| 03/08/2006 | EP1631287A2 Novel long-acting medicament combinations comprising an anticholinergic agent and a $g(b)2-adrenoreceptor antagonist for the treatment of respiratory tract diseases |
| 03/08/2006 | EP1631278A1 Combination chemotherapy comprising capecitabine and a liposomal platinum complex |
| 03/08/2006 | EP1631271A2 Methods and compositions for delivery of catecholic butanes for treatment of tumors |
| 03/08/2006 | EP1631270A2 Methods and compositions for delivery of catecholic butanes for treatment of diseases |
| 03/08/2006 | EP1631269A2 Methods and compositions for delivery of catecholic butanes for treatment of obesity |
| 03/08/2006 | EP1631266A2 A method of treating degenerative disc disease |
| 03/08/2006 | EP1631265A2 Use of various agents for inhibiting fibrous adhesions |
| 03/08/2006 | EP1631264A1 Immunogenic compositions based on microparticles comprising adsorbed toxoid and a polysaccharide-containing antigen |
| 03/08/2006 | EP1631263A2 Orally-dispersible multilayer tablet |
| 03/08/2006 | EP1631262A2 Improved system and method for facilitating hemostatis with an absorbable sponge |
| 03/08/2006 | EP1631261A2 Production of small particles |
| 03/08/2006 | EP1631260A2 Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| 03/08/2006 | EP1631259A1 Otologic nanotechnology |
| 03/08/2006 | EP1631258A1 Combination chemotherapy comprising gemcitabine and a liposomal platinum complex |
| 03/08/2006 | EP1631257A2 Ophthalmic compositions containing a synergistic combination of two polymers |
| 03/08/2006 | EP1631256A2 Dissolvable backing layer for use with a transmucosal delivery device |
| 03/08/2006 | EP1631255A2 Drug delivery system |
| 03/08/2006 | EP1631254A1 Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof |
| 03/08/2006 | EP1631253A1 Sublingual administration of non-steroidal anti-inflammatory pharmacological substances |
| 03/08/2006 | EP1631252A1 Method for producing a solid pharmaceutical composition |
| 03/08/2006 | EP1631251A1 Delayed release tablet with defined core geometry |
| 03/08/2006 | EP1631243A2 Sexual hygienic composition |
| 03/08/2006 | EP1631239A2 Pharmaceutical compositions comprising active vitamin d compounds |
| 03/08/2006 | EP1631234A2 Compositions and methods for the treatment of cns injuries |
| 03/08/2006 | EP1631155A1 Method for producing a chitosan containing salt having a function of lowering blood pressure |
| 03/08/2006 | EP1631146A1 Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments |
| 03/08/2006 | EP1594461A4 Anti-microbial nonwoven wipe |
| 03/08/2006 | EP1461017B1 A pharmaceutical composition for controlled release of a beta-lactam antibiotic |
| 03/08/2006 | EP1429689A4 Rational drug therapy device and methods |
| 03/08/2006 | EP1423157A4 Stabilizing catheter for protein drug delivery |